Understanding how immune cells in the brain interact in glioblastoma
Modulation of Microglia and T Cell Interactions in Malignant Glioma
This project explores how a type of immunotherapy might help patients with glioblastoma by changing the behavior of immune cells in the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11110490 on NIH RePORTER |
What this research studies
Glioblastoma is a challenging brain cancer where the immune system often doesn't fight the tumor effectively. Unlike other cancers, glioblastoma tumors are rich in specific immune cells called macrophages and microglia that actually support tumor growth. This research suggests that a common immunotherapy, anti-PD-1, might work differently in glioblastoma by targeting these supportive immune cells in the brain. By understanding how anti-PD-1 affects these cells, we hope to find new ways to make treatments more effective for patients.
Who could benefit from this research
Good fit: Patients with glioblastoma who have not responded to traditional immunotherapies or who have low T cell counts might be ideal candidates for future treatments based on this research.
Not a fit: Patients with other types of cancer or those without glioblastoma would likely not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to new or improved immunotherapy strategies for glioblastoma patients, especially those who do not respond to current treatments.
How similar studies have performed: Immunotherapy has shown success in other cancers, but its effectiveness in glioblastoma has been limited, making this approach of targeting innate immunity a novel direction.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Heimberger, Amy Beth — Northwestern University
- Study coordinator: Heimberger, Amy Beth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.